Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
L01BA01
|
| gptkbp:brand |
gptkb:methotrexate
|
| gptkbp:CASNumber |
59-05-2
|
| gptkbp:chemicalFormula |
C20H22N8O5
|
| gptkbp:contraindication |
gptkb:liver_disease
pregnancy |
| https://www.w3.org/2000/01/rdf-schema#label |
Rheumatrex
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
DAVA Pharmaceuticals
|
| gptkbp:mechanismOfAction |
dihydrofolate reductase inhibitor
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
injection
oral |
| gptkbp:sideEffect |
nausea
fatigue liver toxicity mouth sores |
| gptkbp:usedFor |
psoriasis
rheumatoid arthritis |
| gptkbp:bfsParent |
gptkb:methotrexate
|
| gptkbp:bfsLayer |
7
|